Lexington Observational Study of Treatment With Compounded Pain Creams
NCT02195752 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 26
Last updated 2015-05-12
Summary
A two-year + 3 Mo. observational study to track compliance and outcomes in adult patients prescribed compounded pharmaceutical creams for the treatment of pain. The project is designed to accumulate tracking information from both patients and physicians over the course of therapy as a supplement to the ordinary care that the patients will normally receive. We seek to discover aspects of successful and unsuccessful treatment using topical pain creams. This information will be analyzed and reports prepared of observations and emergent findings. These reports will be sent during the study every 1 or 2 months to patients, physicians and pharmacists who are participating in the Study. A final compilation of findings and observations will be circulated to participating patients, physicians and pharmacists.
Conditions
- Chronic Pain
- Acute Pain
Interventions
- OTHER
-
Compounded Pain Cream
All patients will have been prescribed a topical pain cream prepared by a qualified compounding pharmacy
Sponsors & Collaborators
-
Palm Beach CRO
collaborator UNKNOWN -
Lexington Independent Studies, LLC
lead INDUSTRY
Principal Investigators
-
Stephen A. Raymond, PhD · Research and Marketing Consultants
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-11-30
- Primary Completion
- 2015-04-30
- Completion
- 2015-05-31
Countries
- United States
Study Locations
More Related Trials
-
Long-Term Safety and Tolerability Study of NKTR-181 in Subjects With Chronic Low Back Pain or Chronic Non-Cancer Pain
NCT02367820 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label, Extension Study to Evaluate the Safety of Hydrocodone Bitartrate Extended-Release Tablets
NCT01922739 ·Status: COMPLETED ·Phase: PHASE3
-
Oxycodone DETERx™ Versus Placebo in Chronic Low Back Pain (CLBP)
NCT01685684 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back Pain
NCT00449176 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Two-way, Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers
NCT01677065 ·Status: COMPLETED
-
Bioequivalency Study of Oxymorphone Hydrochloride 10 mg Tablets Under Fasted Conditions
NCT01210638 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
NCT01789970 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of LASER Photobiomodulation Therapy on Chronic Pain and Opioid Weaning
NCT03437967 ·Status: TERMINATED ·Phase: NA
-
A Study of Pain Relief in Low Back Pain
NCT00325949 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Open-label, Multiple-dose, Two-sequence, Two-period Crossover Study to Investigate The Pharmacokinetics Between a GL2907 and Oxycontin CR Tab. 10mg in Healthy Male Volunteers
NCT01779492 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study Comparing Naltrexone SR/Bupropion SR Trilayer Tablets From Two Manufacturers
NCT02259179 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets
NCT01099709 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Determine the Fasting Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets
NCT01100086 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of Different Amounts of Tablets of a New and a Marketed Tablet Formulation in Healthy Adults
NCT03137030 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of a New and a Marketed Tablet Formulation Under Fasted and Fed Conditions in Healthy Adults
NCT03137017 ·Status: WITHDRAWN ·Phase: PHASE1
-
Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fed Conditions
NCT00857142 ·Status: COMPLETED ·Phase: PHASE1
-
To Determine the Fasting Bioequivalence of Reformulated OXY Tablets Manufactured at Two Different Facilities
NCT01101321 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain
NCT01452529 ·Status: COMPLETED ·Phase: PHASE3
-
Conversion to Embeda With Rescue Trial
NCT01179191 ·Status: TERMINATED ·Phase: PHASE4
-
Slow Opioid Tapering Pilot Study of Patients Using Chronic Opioid Therapy
NCT05297396 ·Status: COMPLETED ·Phase: NA
-
Optimizing Open Label Placebo Rationales
NCT05952960 ·Status: COMPLETED ·Phase: NA
-
A Study to Determine the Fasting Bioequivalence of Reformulated OXY Tablets Manufactured at Two Different Facilities
NCT01101308 ·Status: COMPLETED ·Phase: PHASE1
-
To Determine the Fasting Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets
NCT01101165 ·Status: COMPLETED ·Phase: PHASE1
-
Long-Term Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Pain
NCT01115569 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing LTG-001 SDD Formulation To LTG-001 Crystalline Immediate Release Tablets In Healthy Participants
NCT07341152 ·Status: COMPLETED ·Phase: PHASE1